-
公开(公告)号:US20220152226A1
公开(公告)日:2022-05-19
申请号:US17437417
申请日:2020-03-27
IPC分类号: A61K49/00 , A61K47/69 , C08G65/337 , C08G18/28 , C08G18/71
摘要: In an embodiment, the present disclosure relates to a targeting platform that includes a targeted delivery system including an agent. In some embodiments, the targeted delivery system is modified by fluorination. In some embodiments, the targeted delivery system is electrically charge neutral. In a further embodiment, the present disclosure relates to a method that includes fluorinating a targeting compound with a fluorinating reagent and loading an agent with the fluorinated targeting compound to thereby form a micelle. In an additional embodiment, the present disclosure relates to a targeting platform that includes a fluorinated polymeric system including an agent. In another embodiment, the present disclosure relates to a method that includes fluorinating a targeting compound with a fluorinating reagent and loading an agent with the fluorinated targeting compound to thereby form a micelle. Additionally, the method can include administering the fluorinated targeting compound to a subject.
-
公开(公告)号:US20220133671A1
公开(公告)日:2022-05-05
申请号:US17430287
申请日:2020-02-10
IPC分类号: A61K31/215 , A61P35/00 , A61K31/351 , A61K31/401 , A61K31/4406 , A61K31/4402 , A61K31/4422 , A61K31/445 , A61K31/455 , A61K31/55 , A61K31/60
摘要: The present disclosure relates to methods of preventing or inhibiting fibrosis using small molecule sialidase inhibitors. The present disclosure also relates to methods treating obesity, liver inflammation, steatosis, and cancer. These methods can involve administering the compounds to a patent at risk of developing fibrosis inflammation, obesity, steatosis, or cancer, in a manner that inhibits NEU3.
-
公开(公告)号:US20220121915A1
公开(公告)日:2022-04-21
申请号:US17504279
申请日:2021-10-18
申请人: Arizona Board of Regents on behalf of Arizona State University , The Texas A&M University System
发明人: Ankit Wagle , Sarma Vrudhula , Sunil Khatri
摘要: A configurable binary neural network (BNN) application-specific integrated circuit (ASIC) using a network of programmable threshold logic standard cells is provided. A new architecture is presented for a BNN that uses an optimal schedule for executing the operations of an arbitrary BNN. This architecture, also referred to herein as TULIP, is designed with the goal of maximizing energy efficiency per classification. At the top-level, TULIP consists of a collection of unique processing elements (TULIP-PEs) that are organized in a single instruction, multiple data (SIMD) fashion. Each TULIP-PE consists of a small network of binary neurons, and a small amount of local memory per neuron. Novel algorithms are presented herein for mapping arbitrary nodes of a BNN onto the TULIP-PEs. Comparison results show that TULIP is consistently 3× more energy-efficient than conventional designs, without any penalty in performance, area, or accuracy.
-
公开(公告)号:US20220120681A1
公开(公告)日:2022-04-21
申请号:US17502632
申请日:2021-10-15
发明人: Iltai Isaac KIM , Yang LIE , Jae Sung PARK
IPC分类号: G01N21/552 , G01B11/06 , G01N21/958
摘要: The present disclosure relates to methods for evaluating features of objects such as liquid droplets and surfaces. More particularly, the present disclosure relates to methods for measuring features such as the contact angle and the thickness of an object such as a liquid droplet or a fingerprint as well as related compositions for evaluation.
-
35.
公开(公告)号:US20220096485A1
公开(公告)日:2022-03-31
申请号:US17494759
申请日:2021-10-05
发明人: Dai Lu , Chang-Jiang Qiao , Boqiao Fu , Anantha Lakshmi Duddupudi , Zhixing Wu
IPC分类号: A61K31/519
摘要: Functionalized pyrano[2,3-d]pyrimidin-7-one derivatives, methods for making the derivatives, and methods of using the derivatives as protein kinase inhibitors.
-
公开(公告)号:US20220090075A1
公开(公告)日:2022-03-24
申请号:US17523456
申请日:2021-11-10
发明人: Scott Victor Dindot
IPC分类号: C12N15/113 , C07H21/04
摘要: Disclosed herein are antisense oligonucleotides that are capable of inducing expression of ubiquitin-protein ligase E3A (UBE3A) from the paternal allele in animal or human neurons. The oligonucleotides target the suppressor of the UBE3A paternal allele by hybridization to SNHG14 long non-coding RNA at the 5′-end of UBE3A-AS, which is downstream of SNORD115-45 snoRNA. Also disclosed are pharmaceutical compositions and methods for treatment of Angelman syndrome.
-
公开(公告)号:US20220017235A1
公开(公告)日:2022-01-20
申请号:US17180326
申请日:2021-02-19
发明人: Bochan Lee , Moble Benedict
摘要: An autonomous landing system for vertical landing aircraft includes a vertical landing aircraft including a powertrain and an onboard camera, a motion-stabilized visual cue including a visual indicator, wherein the visual cue is configured to maintain a fixed orientation of the visual indicator with respect to a horizon, and an autonomous control system configured to control a position of the aircraft with respect to the visual indicator of the visual cue based on image data captured by the onboard camera.
-
公开(公告)号:US20220016310A1
公开(公告)日:2022-01-20
申请号:US17395116
申请日:2021-08-05
IPC分类号: A61L24/00 , A61L24/04 , C08G18/10 , C08G18/73 , C08G18/83 , C08J9/36 , A61L15/26 , A61L27/50 , A61L31/14 , A61L31/16 , A61L15/46 , A61L27/18 , A61L27/56 , A61L15/42 , A61L31/06 , A61L27/54
摘要: An embodiment includes a system comprising a thermoset polyurethane shape memory polymer (SMP) foam that includes at least one antimicrobial agent. The antimicrobial agent may include at least one phenolic acid that is a pendent group chemically bonded to a polyurethane polymer chain of the SMP foam. Other embodiments are described herein.
-
公开(公告)号:US11225510B2
公开(公告)日:2022-01-18
申请号:US16806641
申请日:2020-03-02
发明人: James L. Smith , Jerome Escano
摘要: The subject invention pertains to a modified lantibiotic containing an intact cysteine at the C-terminus, particularly, a cysteine that is not decarboxylated and that contains a free carboxyl group. Derivatives of the modified lantibiotic comprising a moiety conjugated to the carboxyl group of the terminal cysteine are also provided. A bacterium that produces a modified lantibiotic having an intact cysteine at the C-terminus are also provided, wherein the bacterium is genetically modified to inactivate a gene that encodes a decarboxylase enzyme that decarboxylates the cysteine at the C-terminus of a precursor lantibiotic. Methods of producing a modified lantibiotic having an intact cysteine at the C-terminus by culturing a bacterium that synthesizes the modified lantibiotic and purifying the lantibiotic are also provided. Mutants of lantibiotics, particularly, mutacin 1140 having higher anti-bacterial activity or higher bacterial expression compared to mutacin 1140 are also provided.
-
公开(公告)号:US20220009300A1
公开(公告)日:2022-01-13
申请号:US17321048
申请日:2021-05-14
发明人: Moble Benedict , Sean M. McHugh , Chase B. Wiley , Ramsay A. Ramsey , Adam Kellen , Yin Lu Young
摘要: An amphibious vehicle for traversing land and bodies of water includes a chassis, and a cycloidal propeller coupled to the chassis and which includes a plurality of cycloidal propeller blades rotatably coupled to the chassis and each extending parallel a rotational axis of the cycloidal propeller, and an extension/retraction system configured to extend the plurality of cycloidal propeller blades away from the chassis and to retract the plurality of cycloidal propeller blades towards the chassis.
-
-
-
-
-
-
-
-
-